Segment disclosures

Company overview

DAVITA INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

18 dimension combinations 436 retained observations 39 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Intersegment Elimination · U.S.Dialysis And Related Lab Services

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=dva:U.S.DialysisAndRelatedLabServicesMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30-11361000 USD20260804Open filing evidence
2026-01-01 – 2026-06-30-31833000 USD20260804Open filing evidence
2026-01-01 – 2026-03-31-20472000 USD20260505Open filing evidence
2025-07-01 – 2025-09-30-11932000 USD20251029Open filing evidence
2025-01-01 – 2025-09-30-40382000 USD20251029Open filing evidence
2025-04-01 – 2025-06-30-16716000 USD20260804Open filing evidence
2025-01-01 – 2025-06-30-28450000 USD20260804Open filing evidence
2025-01-01 – 2025-03-31-11734000 USD20260505Open filing evidence
2024-07-01 – 2024-09-30-16140000 USD20251029Open filing evidence
2024-01-01 – 2024-09-30-53528000 USD20251029Open filing evidence
2024-04-01 – 2024-06-30-12925000 USD20250805Open filing evidence
2024-01-01 – 2024-06-30-37389000 USD20250805Open filing evidence

Intersegment Elimination · US Dialysis And Related Lab Services

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=dva:USDialysisAndRelatedLabServicesMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31-60958000 USD20260211Open filing evidence
2025-01-01 – 2025-03-31-11734000 USD20250512Open filing evidence
2024-01-01 – 2024-12-31-71747000 USD20260211Open filing evidence
2024-07-01 – 2024-09-30-16140000 USD20241029Open filing evidence
2024-01-01 – 2024-09-30-53528000 USD20241029Open filing evidence
2024-04-01 – 2024-06-30-12925000 USD20240806Open filing evidence
2024-01-01 – 2024-06-30-37389000 USD20240806Open filing evidence
2024-01-01 – 2024-03-31-24463000 USD20250512Open filing evidence
2023-01-01 – 2023-12-31-88222000 USD20260211Open filing evidence
2023-07-01 – 2023-09-30-24289000 USD20241029Open filing evidence
2023-01-01 – 2023-09-30-66698000 USD20241029Open filing evidence
2023-04-01 – 2023-06-30-20361000 USD20240806Open filing evidence
2023-01-01 – 2023-06-30-42410000 USD20240806Open filing evidence
2022-07-01 – 2022-09-30-22957000 USD20231107Open filing evidence
2022-01-01 – 2022-09-30-64516000 USD20231107Open filing evidence
2021-07-01 – 2021-09-30-22104000 USD20221031Open filing evidence
2021-01-01 – 2021-09-30-70424000 USD20221031Open filing evidence
2021-01-01 – 2021-03-31-27003000 USD20210429Open filing evidence
2020-01-01 – 2020-12-31-145286000 USD20210212Open filing evidence
2020-07-01 – 2020-09-30-37317000 USD20201029Open filing evidence
2020-01-01 – 2020-09-30-104987000 USD20201029Open filing evidence
2020-04-01 – 2020-06-30-35429000 USD20200730Open filing evidence
2020-01-01 – 2020-06-30-67670000 USD20200730Open filing evidence
2020-01-01 – 2020-03-31-32242000 USD20210429Open filing evidence
2019-01-01 – 2019-12-31-132325000 USD20210212Open filing evidence
2019-07-01 – 2019-09-30-32362000 USD20201029Open filing evidence
2019-01-01 – 2019-09-30-93337000 USD20201029Open filing evidence
2019-04-01 – 2019-06-30-30334000 USD20200730Open filing evidence
2019-01-01 – 2019-06-30-60975000 USD20200730Open filing evidence
2019-01-01 – 2019-03-31-30641000 USD20200505Open filing evidence
2018-01-01 – 2018-12-31-92950000 USD20210212Open filing evidence
2018-07-01 – 2018-09-30-25424000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-01-01 – 2018-09-30-63943000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-04-01 – 2018-06-30-20096000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-06-30-38519000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-03-31-18422000 USD2019-05-07 · 21:10:04.000ZOpen filing evidence
2017-01-01 – 2017-12-31-55176000 USD20200221Open filing evidence
2017-07-01 – 2017-09-30-13475000 USD20181107Open filing evidence
2017-01-01 – 2017-09-30-38559000 USD20181107Open filing evidence
2016-01-01 – 2016-12-31-27355000 USD2019-02-22 · 21:07:40.000ZOpen filing evidence

Intersegment Elimination · All Other Segments

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30-3087000 USD20260804Open filing evidence
2026-01-01 – 2026-06-30-6375000 USD20260804Open filing evidence
2026-01-01 – 2026-03-31-3288000 USD20260505Open filing evidence
2025-01-01 – 2025-12-31-11203000 USD20260211Open filing evidence
2025-07-01 – 2025-09-30-2771000 USD20251029Open filing evidence
2025-01-01 – 2025-09-30-8336000 USD20251029Open filing evidence
2025-04-01 – 2025-06-30-2836000 USD20260804Open filing evidence
2025-01-01 – 2025-06-30-5565000 USD20260804Open filing evidence
2025-01-01 – 2025-03-31-2728000 USD20260505Open filing evidence
2024-01-01 – 2024-12-31-13910000 USD20260211Open filing evidence
2024-07-01 – 2024-09-30-2598000 USD20251029Open filing evidence
2024-01-01 – 2024-09-30-9168000 USD20251029Open filing evidence
2024-04-01 – 2024-06-30-3823000 USD20250805Open filing evidence
2024-01-01 – 2024-06-30-6570000 USD20250805Open filing evidence
2024-01-01 – 2024-03-31-2747000 USD20250512Open filing evidence
2023-01-01 – 2023-12-31-7852000 USD20260211Open filing evidence
2023-07-01 – 2023-09-30-2232000 USD20241029Open filing evidence
2023-01-01 – 2023-09-30-5007000 USD20241029Open filing evidence
2023-04-01 – 2023-06-30-1408000 USD20240806Open filing evidence
2023-01-01 – 2023-06-30-2774000 USD20240806Open filing evidence
2023-01-01 – 2023-03-31-1368000 USD20240502Open filing evidence
2022-01-01 – 2022-12-31-4206000 USD20230222Open filing evidence
2021-01-01 – 2021-12-31-4294000 USD20230222Open filing evidence
2021-07-01 – 2021-09-300 USD20211028Open filing evidence
2021-01-01 – 2021-09-30-4294000 USD20221031Open filing evidence
2020-01-01 – 2020-12-31-16743000 USD20230222Open filing evidence
2020-07-01 – 2020-09-30-4079000 USD20211028Open filing evidence
2020-01-01 – 2020-09-30-12402000 USD20211028Open filing evidence
2020-04-01 – 2020-06-30-4171000 USD20200730Open filing evidence
2020-01-01 – 2020-06-30-8324000 USD20200730Open filing evidence
2020-01-01 – 2020-03-31-4152000 USD20200505Open filing evidence
2019-01-01 – 2019-12-31-14030000 USD20210212Open filing evidence
2019-07-01 – 2019-09-30-3483000 USD20201029Open filing evidence
2019-01-01 – 2019-09-30-10222000 USD20201029Open filing evidence
2019-04-01 – 2019-06-30-3403000 USD20200730Open filing evidence
2019-01-01 – 2019-06-30-6739000 USD20200730Open filing evidence
2019-01-01 – 2019-03-31-3336000 USD20200505Open filing evidence
2018-01-01 – 2018-12-31-34236000 USD20210212Open filing evidence
2018-07-01 – 2018-09-30-8361000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-01-01 – 2018-09-30-27748000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-04-01 – 2018-06-30-9189000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-06-30-19387000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-03-31-10199000 USD2019-05-07 · 21:10:04.000ZOpen filing evidence
2017-01-01 – 2017-12-31-24603000 USD20200221Open filing evidence
2017-07-01 – 2017-09-30-5996000 USD20181107Open filing evidence
2017-01-01 – 2017-09-30-18488000 USD20181107Open filing evidence
2016-01-01 – 2016-12-31-24739000 USD2019-02-22 · 21:07:40.000ZOpen filing evidence

Operating Segments · Other Operating Segments With Intersegment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=dva:OtherOperatingSegmentsWithIntersegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30556709000 USD20260804Open filing evidence
2026-01-01 – 2026-06-301054315000 USD20260804Open filing evidence
2026-01-01 – 2026-03-31497607000 USD20260505Open filing evidence
2025-01-01 – 2025-12-311922286000 USD20260211Open filing evidence
2025-07-01 – 2025-09-30454890000 USD20251029Open filing evidence
2025-01-01 – 2025-09-301355401000 USD20251029Open filing evidence
2025-04-01 – 2025-06-30485687000 USD20260804Open filing evidence
2025-01-01 – 2025-06-30900510000 USD20260804Open filing evidence
2025-01-01 – 2025-03-31414822000 USD20260505Open filing evidence
2024-01-01 – 2024-12-311510490000 USD20260211Open filing evidence
2024-07-01 – 2024-09-30376328000 USD20251029Open filing evidence
2024-01-01 – 2024-09-301080393000 USD20251029Open filing evidence
2024-04-01 – 2024-06-30362460000 USD20250805Open filing evidence
2024-01-01 – 2024-06-30704065000 USD20250805Open filing evidence
2024-01-01 – 2024-03-31341605000 USD20250512Open filing evidence
2023-01-01 – 2023-12-311299223000 USD20260211Open filing evidence
2022-01-01 – 2022-12-311101326000 USD20250213Open filing evidence

Operating Segments · U.S.Dialysis With Intersegment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=dva:U.S.DialysisWithIntersegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-303011823000 USD20260804Open filing evidence
2026-01-01 – 2026-06-305953525000 USD20260804Open filing evidence
2026-01-01 – 2026-03-312941701000 USD20260505Open filing evidence
2025-07-01 – 2025-09-302980040000 USD20251029Open filing evidence
2025-01-01 – 2025-09-308716599000 USD20251029Open filing evidence
2025-04-01 – 2025-06-302913391000 USD20260804Open filing evidence
2025-01-01 – 2025-06-305736560000 USD20260804Open filing evidence
2025-01-01 – 2025-03-312823169000 USD20260505Open filing evidence
2024-07-01 – 2024-09-302906000000 USD20251029Open filing evidence
2024-01-01 – 2024-09-308503170000 USD20251029Open filing evidence
2024-04-01 – 2024-06-302841010000 USD20250805Open filing evidence
2024-01-01 – 2024-06-305597171000 USD20250805Open filing evidence

Operating Segments · US Dialysis And Related Lab Services

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=dva:USDialysisAndRelatedLabServicesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-302906000000 USD20241029Open filing evidence
2024-01-01 – 2024-09-308503170000 USD20241029Open filing evidence
2024-01-01 – 2024-03-312756160000 USD20240502Open filing evidence
2023-01-01 – 2023-12-3110936998000 USD20240214Open filing evidence
2023-07-01 – 2023-09-302785306000 USD20241029Open filing evidence
2023-01-01 – 2023-09-308128081000 USD20241029Open filing evidence
2023-01-01 – 2023-03-312612160000 USD20240502Open filing evidence
2022-01-01 – 2022-12-3110599809000 USD20240214Open filing evidence
2022-07-01 – 2022-09-302703253000 USD20221031Open filing evidence
2022-01-01 – 2022-09-307941589000 USD20221031Open filing evidence
2022-04-01 – 2022-06-302663240000 USD20220801Open filing evidence
2022-01-01 – 2022-06-305238336000 USD20220801Open filing evidence
2022-01-01 – 2022-03-312575096000 USD20220505Open filing evidence
2021-01-01 – 2021-12-3110666963000 USD20240214Open filing evidence
2021-07-01 – 2021-09-302698046000 USD20221031Open filing evidence
2021-01-01 – 2021-09-307964263000 USD20221031Open filing evidence
2021-04-01 – 2021-06-302676338000 USD20220801Open filing evidence
2021-01-01 – 2021-06-305266217000 USD20220801Open filing evidence
2021-01-01 – 2021-03-312589878000 USD20220505Open filing evidence
2020-01-01 – 2020-12-3110659935000 USD20220211Open filing evidence
2020-07-01 – 2020-09-302694219000 USD20201029Open filing evidence
2020-01-01 – 2020-09-307985785000 USD20201029Open filing evidence
2020-04-01 – 2020-06-302674944000 USD20200730Open filing evidence
2020-01-01 – 2020-06-305291567000 USD20200730Open filing evidence
2020-01-01 – 2020-03-312616623000 USD20210429Open filing evidence
2019-01-01 – 2019-12-3110562906000 USD20220211Open filing evidence
2019-07-01 – 2019-09-302691427000 USD20201029Open filing evidence
2019-01-01 – 2019-09-307876072000 USD20201029Open filing evidence
2019-04-01 – 2019-06-302637494000 USD20200730Open filing evidence
2019-01-01 – 2019-06-305184645000 USD20200730Open filing evidence
2019-01-01 – 2019-03-312547151000 USD20200505Open filing evidence
2018-01-01 – 2018-12-3110335949000 USD20210212Open filing evidence
2018-07-01 – 2018-09-302576801000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-01-01 – 2018-09-307703044000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-04-01 – 2018-06-302588343000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-06-305126243000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-03-312537900000 USD2019-05-07 · 21:10:04.000ZOpen filing evidence
2017-01-01 – 2017-12-319360065000 USD20200221Open filing evidence
2017-07-01 – 2017-09-302370474000 USD20181107Open filing evidence
2017-01-01 – 2017-09-306966882000 USD20181107Open filing evidence
2017-04-01 – 2017-06-302325215000 USD20180801Open filing evidence
2017-01-01 – 2017-06-304596408000 USD20180801Open filing evidence
2016-01-01 – 2016-12-319138189000 USD2019-02-22 · 21:07:40.000ZOpen filing evidence

Operating Segments · US Dialysis And Related Lab Services With Intersegment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=dva:USDialysisAndRelatedLabServicesWithIntersegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3111792944000 USD20260211Open filing evidence
2025-01-01 – 2025-03-312823169000 USD20250512Open filing evidence
2024-01-01 – 2024-12-3111390717000 USD20260211Open filing evidence
2024-01-01 – 2024-03-312756160000 USD20250512Open filing evidence
2023-01-01 – 2023-12-3110936998000 USD20260211Open filing evidence
2022-01-01 – 2022-12-3110599809000 USD20250213Open filing evidence

Operating Segments · All Other Segments

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-30376328000 USD20241029Open filing evidence
2024-01-01 – 2024-09-301080393000 USD20241029Open filing evidence
2024-01-01 – 2024-03-31341605000 USD20240502Open filing evidence
2023-01-01 – 2023-12-311299223000 USD20240214Open filing evidence
2023-07-01 – 2023-09-30362547000 USD20241029Open filing evidence
2023-01-01 – 2023-09-30938024000 USD20241029Open filing evidence
2023-04-01 – 2023-06-30291523000 USD20230803Open filing evidence
2023-01-01 – 2023-06-30575477000 USD20230803Open filing evidence
2023-01-01 – 2023-03-31283954000 USD20240502Open filing evidence
2022-01-01 – 2022-12-311101326000 USD20240214Open filing evidence
2022-07-01 – 2022-09-30268398000 USD20221031Open filing evidence
2022-01-01 – 2022-09-30815933000 USD20221031Open filing evidence
2022-04-01 – 2022-06-30282906000 USD20230803Open filing evidence
2022-01-01 – 2022-06-30547534000 USD20230803Open filing evidence
2022-01-01 – 2022-03-31264628000 USD20230508Open filing evidence
2021-01-01 – 2021-12-311046924000 USD20240214Open filing evidence
2021-07-01 – 2021-09-30262377000 USD20221031Open filing evidence
2021-01-01 – 2021-09-30785285000 USD20221031Open filing evidence
2021-01-01 – 2021-03-31261419000 USD20220505Open filing evidence
2020-01-01 – 2020-12-311052698000 USD20230222Open filing evidence
2020-07-01 – 2020-09-30271243000 USD20211028Open filing evidence
2020-01-01 – 2020-09-30776886000 USD20211028Open filing evidence
2020-04-01 – 2020-06-30244635000 USD20200730Open filing evidence
2020-01-01 – 2020-06-30505643000 USD20200730Open filing evidence
2020-01-01 – 2020-03-31261008000 USD20200505Open filing evidence
2019-01-01 – 2019-12-31971928000 USD20210212Open filing evidence
2019-07-01 – 2019-09-30248496000 USD20201029Open filing evidence
2019-01-01 – 2019-09-30717382000 USD20201029Open filing evidence
2019-04-01 – 2019-06-30238948000 USD20200730Open filing evidence
2019-01-01 – 2019-06-30468886000 USD20200730Open filing evidence
2019-01-01 – 2019-03-31229938000 USD20200505Open filing evidence
2018-01-01 – 2018-12-311196088000 USD20210212Open filing evidence
2018-07-01 – 2018-09-30304314000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-01-01 – 2018-09-30972374000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-04-01 – 2018-06-30327895000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-06-30668060000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-03-31340165000 USD2019-05-07 · 21:10:04.000ZOpen filing evidence
2017-01-01 – 2017-12-311596348000 USD20200221Open filing evidence
2017-07-01 – 2017-09-30414068000 USD20181107Open filing evidence
2017-01-01 – 2017-09-301185886000 USD20181107Open filing evidence
2017-04-01 – 2017-06-30393593000 USD20180801Open filing evidence
2017-01-01 – 2017-06-30771819000 USD20180801Open filing evidence
2016-01-01 – 2016-12-311621372000 USD2019-02-22 · 21:07:40.000ZOpen filing evidence

Other Operating Segments With Intersegment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dva:OtherOperatingSegmentsWithIntersegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30551766000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2026-01-01 – 2026-09-301606081000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-07-01 – 2025-09-30454890000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-01-01 – 2025-09-301355401000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence

U.S.Dialysis And Related Lab Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dva:U.S.DialysisAndRelatedLabServicesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-303028470000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2026-01-01 – 2026-09-308950162000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2026-04-01 – 2026-06-303000462000 USD20260804Open filing evidence
2026-01-01 – 2026-06-305921692000 USD20260804Open filing evidence
2026-01-01 – 2026-03-312921229000 USD20260505Open filing evidence
2025-07-01 – 2025-09-302968108000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-01-01 – 2025-09-308676217000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-04-01 – 2025-06-302896675000 USD20260804Open filing evidence
2025-01-01 – 2025-06-305708110000 USD20260804Open filing evidence
2025-01-01 – 2025-03-312811435000 USD20260505Open filing evidence
2024-07-01 – 2024-09-302889860000 USD20251029Open filing evidence
2024-01-01 – 2024-09-308449642000 USD20251029Open filing evidence
2024-04-01 – 2024-06-302828085000 USD20250805Open filing evidence
2024-01-01 – 2024-06-305559782000 USD20250805Open filing evidence

U.S.Dialysis And Related Lab Services · Intersegment Elimination

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dva:U.S.DialysisAndRelatedLabServicesMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30-22008000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2026-01-01 – 2026-09-30-53841000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-07-01 – 2025-09-30-11932000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-01-01 – 2025-09-30-40382000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence

U.S.Dialysis With Intersegment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dva:U.S.DialysisWithIntersegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-303050478000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2026-01-01 – 2026-09-309004003000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-07-01 – 2025-09-302980040000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-01-01 – 2025-09-308716599000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence

US Dialysis And Related Lab Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dva:USDialysisAndRelatedLabServicesMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3111731986000 USD20260211Open filing evidence
2025-01-01 – 2025-03-312811435000 USD20250512Open filing evidence
2024-01-01 – 2024-12-3111318970000 USD20260211Open filing evidence
2024-07-01 – 2024-09-302889860000 USD20241029Open filing evidence
2024-01-01 – 2024-09-308449642000 USD20241029Open filing evidence
2024-04-01 – 2024-06-302828085000 USD20240806Open filing evidence
2024-01-01 – 2024-06-305559782000 USD20240806Open filing evidence
2024-01-01 – 2024-03-312731697000 USD20250512Open filing evidence
2023-01-01 – 2023-12-3110848776000 USD20260211Open filing evidence
2023-07-01 – 2023-09-302761017000 USD20241029Open filing evidence
2023-01-01 – 2023-09-308061383000 USD20241029Open filing evidence
2023-04-01 – 2023-06-302710254000 USD20240806Open filing evidence
2023-01-01 – 2023-06-305300365000 USD20240806Open filing evidence
2023-01-01 – 2023-03-312590113000 USD20240502Open filing evidence
2022-01-01 – 2022-12-3110512774000 USD20240214Open filing evidence
2022-07-01 – 2022-09-302680296000 USD20231107Open filing evidence
2022-01-01 – 2022-09-307877073000 USD20231107Open filing evidence
2022-04-01 – 2022-06-302643851000 USD20230803Open filing evidence
2022-01-01 – 2022-06-305196778000 USD20230803Open filing evidence
2022-01-01 – 2022-03-312552927000 USD20230508Open filing evidence
2021-01-01 – 2021-12-3110576167000 USD20240214Open filing evidence
2021-07-01 – 2021-09-302675942000 USD20221031Open filing evidence
2021-01-01 – 2021-09-307893839000 USD20221031Open filing evidence
2021-04-01 – 2021-06-302655021000 USD20220801Open filing evidence
2021-01-01 – 2021-06-305217897000 USD20220801Open filing evidence
2021-01-01 – 2021-03-312562875000 USD20220505Open filing evidence
2020-01-01 – 2020-12-3110514649000 USD20230222Open filing evidence
2020-07-01 – 2020-09-302656902000 USD20211028Open filing evidence
2020-01-01 – 2020-09-307880798000 USD20211028Open filing evidence
2020-04-01 – 2020-06-302639515000 USD20210803Open filing evidence
2020-01-01 – 2020-06-305223897000 USD20210803Open filing evidence
2020-01-01 – 2020-03-312584381000 USD20210429Open filing evidence
2019-01-01 – 2019-12-3110430581000 USD20220211Open filing evidence
2019-07-01 – 2019-09-302659065000 USD20201029Open filing evidence
2019-01-01 – 2019-09-307782735000 USD20201029Open filing evidence
2019-04-01 – 2019-06-302607160000 USD20200730Open filing evidence
2019-01-01 – 2019-06-305123670000 USD20200730Open filing evidence
2019-01-01 – 2019-03-312516510000 USD20200505Open filing evidence
2018-01-01 – 2018-12-3110242999000 USD20210212Open filing evidence
2018-07-01 – 2018-09-302551377000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-01-01 – 2018-09-307639101000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-04-01 – 2018-06-302568247000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-06-305087724000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-03-312519478000 USD2019-05-07 · 21:10:04.000ZOpen filing evidence
2017-01-01 – 2017-12-319304889000 USD20200221Open filing evidence
2017-07-01 – 2017-09-302356999000 USD20181107Open filing evidence
2017-01-01 – 2017-09-306928323000 USD20181107Open filing evidence
2017-04-01 – 2017-06-302311930000 USD20180801Open filing evidence
2017-01-01 – 2017-06-304571324000 USD20180801Open filing evidence
2016-01-01 – 2016-12-319110834000 USD2019-02-22 · 21:07:40.000ZOpen filing evidence

US Dialysis And Related Lab Services · Intersegment Elimination

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dva:USDialysisAndRelatedLabServicesMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31-24463000 USD20240502Open filing evidence
2023-01-01 – 2023-12-31-88222000 USD20240214Open filing evidence
2023-04-01 – 2023-06-30-20361000 USD20230803Open filing evidence
2023-01-01 – 2023-06-30-42410000 USD20230803Open filing evidence
2023-01-01 – 2023-03-31-22047000 USD20240502Open filing evidence
2022-01-01 – 2022-12-31-87035000 USD20240214Open filing evidence
2022-04-01 – 2022-06-30-19389000 USD20230803Open filing evidence
2022-01-01 – 2022-06-30-41558000 USD20230803Open filing evidence
2022-01-01 – 2022-03-31-22169000 USD20230508Open filing evidence
2021-01-01 – 2021-12-31-90796000 USD20240214Open filing evidence
2021-07-01 – 2021-09-30-22104000 USD20211028Open filing evidence
2021-01-01 – 2021-09-30-70424000 USD20211028Open filing evidence
2021-04-01 – 2021-06-30-21317000 USD20220801Open filing evidence
2021-01-01 – 2021-06-30-48320000 USD20220801Open filing evidence
2021-01-01 – 2021-03-31-27003000 USD20220505Open filing evidence
2020-01-01 – 2020-12-31-145286000 USD20230222Open filing evidence
2020-07-01 – 2020-09-30-37317000 USD20211028Open filing evidence
2020-01-01 – 2020-09-30-104987000 USD20211028Open filing evidence
2020-04-01 – 2020-06-30-35429000 USD20210803Open filing evidence
2020-01-01 – 2020-06-30-67670000 USD20210803Open filing evidence
2019-01-01 – 2019-12-31-132325000 USD20220211Open filing evidence

US Dialysis And Related Lab Services · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dva:USDialysisAndRelatedLabServicesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-302841010000 USD20240806Open filing evidence
2024-01-01 – 2024-06-305597171000 USD20240806Open filing evidence
2023-07-01 – 2023-09-302785306000 USD20231107Open filing evidence
2023-01-01 – 2023-09-308128081000 USD20231107Open filing evidence
2023-04-01 – 2023-06-302730615000 USD20240806Open filing evidence
2023-01-01 – 2023-06-305342775000 USD20240806Open filing evidence
2023-01-01 – 2023-03-312612160000 USD20230508Open filing evidence
2022-01-01 – 2022-12-3110599809000 USD20230222Open filing evidence
2022-07-01 – 2022-09-302703253000 USD20231107Open filing evidence
2022-01-01 – 2022-09-307941589000 USD20231107Open filing evidence
2022-04-01 – 2022-06-302663240000 USD20230803Open filing evidence
2022-01-01 – 2022-06-305238336000 USD20230803Open filing evidence
2022-01-01 – 2022-03-312575096000 USD20230508Open filing evidence
2021-01-01 – 2021-12-3110666963000 USD20230222Open filing evidence
2021-07-01 – 2021-09-302698046000 USD20211028Open filing evidence
2021-01-01 – 2021-09-307964263000 USD20211028Open filing evidence
2021-04-01 – 2021-06-302676338000 USD20210803Open filing evidence
2021-01-01 – 2021-06-305266217000 USD20210803Open filing evidence
2020-01-01 – 2020-12-3110659935000 USD20230222Open filing evidence
2020-07-01 – 2020-09-302694219000 USD20211028Open filing evidence
2020-01-01 – 2020-09-307985785000 USD20211028Open filing evidence
2020-04-01 – 2020-06-302674944000 USD20210803Open filing evidence
2020-01-01 – 2020-06-305291567000 USD20210803Open filing evidence

All Other Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30549656000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2026-01-01 – 2026-09-301597596000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2026-04-01 – 2026-06-30553622000 USD20260804Open filing evidence
2026-01-01 – 2026-06-301047940000 USD20260804Open filing evidence
2026-01-01 – 2026-03-31494319000 USD20260505Open filing evidence
2025-01-01 – 2025-12-311911083000 USD20260211Open filing evidence
2025-07-01 – 2025-09-30452119000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-01-01 – 2025-09-301347065000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-04-01 – 2025-06-30482851000 USD20260804Open filing evidence
2025-01-01 – 2025-06-30894945000 USD20260804Open filing evidence
2025-01-01 – 2025-03-31412094000 USD20260505Open filing evidence
2024-01-01 – 2024-12-311496580000 USD20260211Open filing evidence
2024-07-01 – 2024-09-30373730000 USD20251029Open filing evidence
2024-01-01 – 2024-09-301071225000 USD20251029Open filing evidence
2024-04-01 – 2024-06-30358637000 USD20250805Open filing evidence
2024-01-01 – 2024-06-30697495000 USD20250805Open filing evidence
2024-01-01 – 2024-03-31338858000 USD20250512Open filing evidence
2023-01-01 – 2023-12-311291371000 USD20260211Open filing evidence
2023-07-01 – 2023-09-30360315000 USD20241029Open filing evidence
2023-01-01 – 2023-09-30933017000 USD20241029Open filing evidence
2023-04-01 – 2023-06-30290115000 USD20240806Open filing evidence
2023-01-01 – 2023-06-30572703000 USD20240806Open filing evidence
2023-01-01 – 2023-03-31282586000 USD20240502Open filing evidence
2022-01-01 – 2022-12-311097120000 USD20240214Open filing evidence
2022-07-01 – 2022-09-30268398000 USD20231107Open filing evidence
2022-01-01 – 2022-09-30815933000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30282906000 USD20230803Open filing evidence
2022-01-01 – 2022-06-30547534000 USD20230803Open filing evidence
2022-01-01 – 2022-03-31264628000 USD20230508Open filing evidence
2021-01-01 – 2021-12-311042630000 USD20240214Open filing evidence
2021-07-01 – 2021-09-30262377000 USD20221031Open filing evidence
2021-01-01 – 2021-09-30780991000 USD20221031Open filing evidence
2021-04-01 – 2021-06-30261489000 USD20220801Open filing evidence
2021-01-01 – 2021-06-30518614000 USD20220801Open filing evidence
2021-01-01 – 2021-03-31257126000 USD20220505Open filing evidence
2020-01-01 – 2020-12-311035955000 USD20230222Open filing evidence
2020-07-01 – 2020-09-30267164000 USD20211028Open filing evidence
2020-01-01 – 2020-09-30764484000 USD20211028Open filing evidence
2020-04-01 – 2020-06-30240464000 USD20210803Open filing evidence
2020-01-01 – 2020-06-30497319000 USD20210803Open filing evidence
2020-01-01 – 2020-03-31256856000 USD20210429Open filing evidence
2019-01-01 – 2019-12-31957898000 USD20220211Open filing evidence
2019-07-01 – 2019-09-30245013000 USD20201029Open filing evidence
2019-01-01 – 2019-09-30707160000 USD20201029Open filing evidence
2019-04-01 – 2019-06-30235545000 USD20200730Open filing evidence
2019-01-01 – 2019-06-30462147000 USD20200730Open filing evidence
2019-01-01 – 2019-03-31226602000 USD20200505Open filing evidence
2018-01-01 – 2018-12-311161852000 USD20210212Open filing evidence
2018-07-01 – 2018-09-30295953000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-01-01 – 2018-09-30944626000 USD2019-11-07 · 00:08:00.000ZOpen filing evidence
2018-04-01 – 2018-06-30318706000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-06-30648673000 USD2019-08-01 · 23:21:18.000ZOpen filing evidence
2018-01-01 – 2018-03-31329966000 USD2019-05-07 · 21:10:04.000ZOpen filing evidence
2017-01-01 – 2017-12-311571745000 USD20200221Open filing evidence
2017-07-01 – 2017-09-30408072000 USD20181107Open filing evidence
2017-01-01 – 2017-09-301167398000 USD20181107Open filing evidence
2017-04-01 – 2017-06-30387469000 USD20180801Open filing evidence
2017-01-01 – 2017-06-30759326000 USD20180801Open filing evidence
2016-01-01 – 2016-12-311596633000 USD2019-02-22 · 21:07:40.000ZOpen filing evidence

All Other Segments · Intersegment Elimination

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30-2110000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2026-01-01 – 2026-09-30-8485000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-07-01 – 2025-09-30-2771000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2025-01-01 – 2025-09-30-8336000 USD2026-10-29 · 21:03:13.000ZOpen filing evidence
2023-01-01 – 2023-12-31-7852000 USD20240214Open filing evidence
2023-07-01 – 2023-09-30-2232000 USD20231107Open filing evidence
2023-01-01 – 2023-09-30-5007000 USD20231107Open filing evidence
2023-01-01 – 2023-03-31-1368000 USD20230508Open filing evidence
2022-01-01 – 2022-12-31-4206000 USD20240214Open filing evidence
2021-01-01 – 2021-12-31-4294000 USD20240214Open filing evidence
2021-04-01 – 2021-06-300 USD20220801Open filing evidence
2021-01-01 – 2021-06-30-4294000 USD20220801Open filing evidence
2021-01-01 – 2021-03-31-4293000 USD20220505Open filing evidence
2020-01-01 – 2020-12-31-16743000 USD20220211Open filing evidence
2020-04-01 – 2020-06-30-4171000 USD20210803Open filing evidence
2020-01-01 – 2020-06-30-8324000 USD20210803Open filing evidence
2020-01-01 – 2020-03-31-4152000 USD20210429Open filing evidence
2019-01-01 – 2019-12-31-14030000 USD20220211Open filing evidence

All Other Segments · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-30362460000 USD20240806Open filing evidence
2024-01-01 – 2024-06-30704065000 USD20240806Open filing evidence
2023-07-01 – 2023-09-30362547000 USD20231107Open filing evidence
2023-01-01 – 2023-09-30938024000 USD20231107Open filing evidence
2023-04-01 – 2023-06-30291523000 USD20240806Open filing evidence
2023-01-01 – 2023-06-30575477000 USD20240806Open filing evidence
2022-07-01 – 2022-09-30268398000 USD20231107Open filing evidence
2022-01-01 – 2022-09-30815933000 USD20231107Open filing evidence
2022-04-01 – 2022-06-30282906000 USD20220801Open filing evidence
2022-01-01 – 2022-06-30547534000 USD20220801Open filing evidence
2021-01-01 – 2021-12-311046924000 USD20220211Open filing evidence
2021-04-01 – 2021-06-30261489000 USD20220801Open filing evidence
2021-01-01 – 2021-06-30522908000 USD20220801Open filing evidence
2021-01-01 – 2021-03-31261419000 USD20210429Open filing evidence
2020-01-01 – 2020-12-311052698000 USD20220211Open filing evidence
2020-04-01 – 2020-06-30244635000 USD20210803Open filing evidence
2020-01-01 – 2020-06-30505643000 USD20210803Open filing evidence
2020-01-01 – 2020-03-31261008000 USD20210429Open filing evidence
2019-01-01 – 2019-12-31971928000 USD20220211Open filing evidence